(INMD) on Tuesday reported earnings of $82.8 million in its fourth quarter. On a per-share basis, the Yokneam, Israel-based company said it had profit of $1.14. Earnings, adjusted for pretax gains, ...
The positive quarter caps a busy year of cost cutting and pressure from an activist investor as Pfizer has sought to turn around company performance. Shares rose 1.2% to $26.51 soon after market open.
Some results have been hidden because they may be inaccessible to you